Firms in Plasma Protein Therapeutics Market Tap into Vast Demand for Immunoglobulins (IG) - TMR Study
07 Nov 2022
Collaborate
Continuous advancements in plasma fractionation technologies spurring growth opportunities for firms in plasma protein therapeutics market; demand for novel plasma protein therapies in wide spectrum of clinical indications to fuel prospects
Plasma-derived IG gathering traction in autoimmune and inflammatory diseases notably in the developing world; off-label use of immunoglobulin anchors value-grab opportunity
WILMINGTON, Del., Nov. 7, 2022 /PRNewswire/ -- The global plasma protein therapy market is poised for promising growth trajectory pivoting on rise in interest of drug manufacturers in developing protein-based therapeutics for a wide variety of clinical indications, including infectious diseases. Wide adoption of special fractionation technologies has paved the way to new array of plasma protein therapeutics. The plasma protein therapeutics market is forecast to advance at a CAGR of 7.0% during 2019 – 2027.
An in-depth study by TMR found that a host of therapeutic proteins such as ceruloplasmin and plasmin have attracted extensive R&D among globally prominent pharmaceutical companies. They are harnessing these for developing plasma-derived protein therapeutics that will be effective in the treatment of range of life-threatening diseases. Of note, plasma-derived IG gathering massive interest in treating autoimmune and inflammatory diseases, presenting firms with colossal revenue streams, found the study.
Get Exclusive PDF Sample Copy of
Plasma Protein Therapeutics Market
– https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10424
A scrutiny of recent plasma protein therapeutics market trends highlight that advances made in purification of several proteins have broadened the global market outlook. Of note, they hold enormous promise in the development of novel plasma protein therapies for being effective in a wide spectrum of clinical indications.
Key Findings of Plasma Protein Therapeutics Market Study
Demand for Immunoglobulins (IG) for Wide Range of Indications Underpins Abundant Opportunities: A wide range of immunoglobulins are approved for clinical use, observed the study authors. The immunoglobulins (IG) segment has been a lucrative one, propelled by rising demand for the plasma protein therapeutics for both approved and off-label use. Indeed, widespread off-label use of immunoglobulins is expected to spur growth prospects, particularly for acute cardiomyopathy, autoimmune blistering diseases, and multifocal motor neuropathy (MMN).
Adoption of Plasma Fractionation Technologies Expanding Avenues: Rise in demand for advanced plasma fractionation technologies to meet quality and regulatory requirements is fueling the growth opportunities for companies in the plasma protein therapeutics market. Moreover, many firms have also expanded plasma fractionation capacities. They have increasingly benefitted from steady advances in protein-engineering technologies to obtain desired therapeutic proteins for a wide variety of cancers, immune disorders, and infections.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=10424
Plasma Protein Therapeutics Market: Key Drivers
Growing use of therapeutic protein drugs in novel therapies in wide spectrum of clinical indications is a key driver of plasma protein therapeutics market. A positive reimbursement framework for plasma protein therapies is also catalyzing the demand.
The expansion of plasma protein therapeutics market is propped by investments on augmenting production capacities of plasma-derived therapies. Stridently, the plasma protein industry has attracted a slew of big investments by a clutch of healthcare companies over the past few decades, reinforced by advancement in protein-engineering technologies.
Regional Growth Dynamics
Prevalence of immune deficiencies in developing world has fueled the growth prospects of the global plasma protein therapeutics market. Emerging regional markets are expected to witness lucrative avenues on the back of rising adoption of IG in a wide variety of clinical indications. A number of protein-based therapeutics have been approved in European nations and the U.S.
Plasma Protein Therapeutics Market: Competition Landscape
Top players are geared toward unveiling novel therapies using plasma fractions by employing advanced and cost-effective fractionating procedures. Various players are keen on entering into collaborations in a bid to spur regulatory approvals.
Some of the key players in plasma protein therapeutics market are China Biologics, Shire Plc., Octapharma USA, Inc., Kedrion, GRIFOLS, S.A, CSL Behring, Biotests, Baxter International, and Grifols.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=10424
Plasma Protein Therapeutics Market Segmentation
Product
Immunoglobulin
Albumin
Coagulation Factor
C1-esterase inhibitorsC1-esterase inhibitors
Others
Application
Secondary Immunodeficiency
Other Indications
Region
North America
Europe
Latin America
Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Anticoagulants Market: The global anticoagulants market is anticipated to reach more than US$ 56.6 Bn by the end of 2031 at a CAGR of 6.2% from 2022 to 2031.
Hyperpigmentation Disorder Treatment Market: The global hyperpigmentation disorder treatment market is anticipated to reach more than US$ 9.5 Bn by the end of 2031 at a CAGR of 8.5% from 2022 to 2031.
Acute Lymphoblastic Leukemia Market: The global acute lymphoblastic leukemia market is anticipated to reach more than US$ 4.5 Bn by the end of 2031 at a CAGR of 7.6% from 2022 to 2031.
Oral Rehydration Solution [ORS] Market: The global oral rehydration solution (ORS) market is anticipated to reach more than US$ 6.71 Bn by 2031 at a CAGR of 9.9% from 2022 to 2031.
Ophthalmic Drugs Market: The ophthalmic drugs market is expected to reach US$ 50.2 Bn by the end of 2031 at a CAGR of 6.83% from 2022 to 2031.
Homeopathic Products Market: The global homeopathic products market is anticipated to reach more than US$ 32.4 Bn by the end of 2031 at a CAGR of 11.6% from 2022 to 2031.
Pain Management Therapeutics Market: The global pain management therapeutics market is anticipated to reach more than US$ 98.0 Bn by the end of 2031 at a CAGR of 2.9% from 2022 to 2031.
Peptide Therapeutics Market: The global peptide therapeutics market is anticipated to reach more than US$ 91.25 Bn by 2031 at a CAGR of 8.8% from 2022 to 2031.
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyse information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Nikhil Sawlani
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
SOURCE Transparency Market Research
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.